Display options
Cite
Schumacher FR, Olama AAA, Berndt SI, et al. Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nat Genet. 2019;51(2):363doi: 10.1038/s41588-018-0330-6.
Schumacher, F. R., Olama, A. A. A., Berndt, S. I., Benlloch, S., Ahmed, M., Saunders, E. J., Dadaev, T., Leongamornlert, D., Anokian, E., Cieza-Borrella, C., Goh, C., Brook, M. N., Sheng, X., Fachal, L., Dennis, J., Tyrer, J., Muir, K., Lophatananon, A., Stevens, V. L., Gapstur, S. M., Carter, B. D., Tangen, C. M., Goodman, P. J., Thompson, I. M., Batra, J., Chambers, S., Moya, L., Clements, J., Horvath, L., Tilley, W., Risbridger, G. P., Gronberg, H., Aly, M., Nordström, T., Pharoah, P., Pashayan, N., Schleutker, J., Tammela, T. L. J., Sipeky, C., Auvinen, A., Albanes, D., Weinstein, S., Wolk, A., Håkansson, N., West, C. M. L., Dunning, A. M., Burnet, N., Mucci, L. A., Giovannucci, E., Andriole, G. L., Cussenot, O., Cancel-Tassin, G., Koutros, S., Beane Freeman, L. E., Sorensen, K. D., Orntoft, T. F., Borre, M., Maehle, L., Grindedal, E. M., Neal, D. E., Donovan, J. L., Hamdy, F. C., Martin, R. M., Travis, R. C., Key, T. J., Hamilton, R. J., Fleshner, N. E., Finelli, A., Ingles, S. A., Stern, M. C., Rosenstein, B. S., Kerns, S. L., Ostrer, H., Lu, Y. J., Zhang, H. W., Feng, N., Mao, X., Guo, X., Wang, G., Sun, Z., Giles, G. G., Southey, M. C., MacInnis, R. J., FitzGerald, L. M., Kibel, A. S., Drake, B. F., Vega, A., Gómez-Caamaño, A., Szulkin, R., Eklund, M., Kogevinas, M., Llorca, J., Castaño-Vinyals, G., Penney, K. L., Stampfer, M., Park, J. Y., Sellers, T. A., Lin, H. Y., Stanford, J. L., Cybulski, C., Wokolorczyk, D., Lubinski, J., Ostrander, E. A., Geybels, M. S., Nordestgaard, B. G., Nielsen, S. F., Weischer, M., Bisbjerg, R., Røder, M. A., Iversen, P., Brenner, H., Cuk, K., Holleczek, B., Maier, C., Luedeke, M., Schnoeller, T., Kim, J., Logothetis, C. J., John, E. M., Teixeira, M. R., Paulo, P., Cardoso, M., Neuhausen, S. L., Steele, L., Ding, Y. C., De Ruyck, K., De Meerleer, G., Ost, P., Razack, A., Lim, J., Teo, S. H., Lin, D. W., Newcomb, L. F., Lessel, D., Gamulin, M., Kulis, T., Kaneva, R., Usmani, N., Singhal, S., Slavov, C., Mitev, V., Parliament, M., Claessens, F., Joniau, S., Van den Broeck, T., Larkin, S., Townsend, P. A., Aukim-Hastie, C., Gago-Dominguez, M., Castelao, J. E., Martinez, M. E., Roobol, M. J., Jenster, G., van Schaik, R. H. N., Menegaux, F., Truong, T., Koudou, Y. A., Xu, J., Khaw, K. T., Cannon-Albright, L., Pandha, H., Michael, A., Thibodeau, S. N., McDonnell, S. K., Schaid, D. J., Lindstrom, S., Turman, C., Ma, J., Hunter, D. J., Riboli, E., Siddiq, A., Canzian, F., Kolonel, L. N., Le Marchand, L., Hoover, R. N., Machiela, M. J., Cui, Z., Kraft, P., Amos, C. I., Conti, D. V., Easton, D. F., Wiklund, F., Chanock, S. J., Henderson, B. E., Kote-Jarai, Z., Haiman, C. A., Eeles, R. A. (2019). Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nature genetics, 51(2), 363. https://doi.org/10.1038/s41588-018-0330-6
Schumacher, Fredrick R, et al. "Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci." Nature genetics vol. 51,2 (2019): 363. doi: https://doi.org/10.1038/s41588-018-0330-6
Schumacher FR, Olama AAA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, Goh C, Brook MN, Sheng X, Fachal L, Dennis J, Tyrer J, Muir K, Lophatananon A, Stevens VL, Gapstur SM, Carter BD, Tangen CM, Goodman PJ, Thompson IM, Batra J, Chambers S, Moya L, Clements J, Horvath L, Tilley W, Risbridger GP, Gronberg H, Aly M, Nordström T, Pharoah P, Pashayan N, Schleutker J, Tammela TLJ, Sipeky C, Auvinen A, Albanes D, Weinstein S, Wolk A, Håkansson N, West CML, Dunning AM, Burnet N, Mucci LA, Giovannucci E, Andriole GL, Cussenot O, Cancel-Tassin G, Koutros S, Beane Freeman LE, Sorensen KD, Orntoft TF, Borre M, Maehle L, Grindedal EM, Neal DE, Donovan JL, Hamdy FC, Martin RM, Travis RC, Key TJ, Hamilton RJ, Fleshner NE, Finelli A, Ingles SA, Stern MC, Rosenstein BS, Kerns SL, Ostrer H, Lu YJ, Zhang HW, Feng N, Mao X, Guo X, Wang G, Sun Z, Giles GG, Southey MC, MacInnis RJ, FitzGerald LM, Kibel AS, Drake BF, Vega A, Gómez-Caamaño A, Szulkin R, Eklund M, Kogevinas M, Llorca J, Castaño-Vinyals G, Penney KL, Stampfer M, Park JY, Sellers TA, Lin HY, Stanford JL, Cybulski C, Wokolorczyk D, Lubinski J, Ostrander EA, Geybels MS, Nordestgaard BG, Nielsen SF, Weischer M, Bisbjerg R, Røder MA, Iversen P, Brenner H, Cuk K, Holleczek B, Maier C, Luedeke M, Schnoeller T, Kim J, Logothetis CJ, John EM, Teixeira MR, Paulo P, Cardoso M, Neuhausen SL, Steele L, Ding YC, De Ruyck K, De Meerleer G, Ost P, Razack A, Lim J, Teo SH, Lin DW, Newcomb LF, Lessel D, Gamulin M, Kulis T, Kaneva R, Usmani N, Singhal S, Slavov C, Mitev V, Parliament M, Claessens F, Joniau S, Van den Broeck T, Larkin S, Townsend PA, Aukim-Hastie C, Gago-Dominguez M, Castelao JE, Martinez ME, Roobol MJ, Jenster G, van Schaik RHN, Menegaux F, Truong T, Koudou YA, Xu J, Khaw KT, Cannon-Albright L, Pandha H, Michael A, Thibodeau SN, McDonnell SK, Schaid DJ, Lindstrom S, Turman C, Ma J, Hunter DJ, Riboli E, Siddiq A, Canzian F, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Cui Z, Kraft P, Amos CI, Conti DV, Easton DF, Wiklund F, Chanock SJ, Henderson BE, Kote-Jarai Z, Haiman CA, Eeles RA. Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nat Genet. 2019 Feb;51(2):363. doi: 10.1038/s41588-018-0330-6. PMID: 30622367.
Copy Download .nbib Format: NLM
Share it on

Nat Genet. 2019 Feb;51(2):363. doi: 10.1038/s41588-018-0330-6.

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.

Nature genetics

Fredrick R Schumacher, Ali Amin Al Olama, Sonja I Berndt, Sara Benlloch, Mahbubl Ahmed, Edward J Saunders, Tokhir Dadaev, Daniel Leongamornlert, Ezequiel Anokian, Clara Cieza-Borrella, Chee Goh, Mark N Brook, Xin Sheng, Laura Fachal, Joe Dennis, Jonathan Tyrer, Kenneth Muir, Artitaya Lophatananon, Victoria L Stevens, Susan M Gapstur, Brian D Carter, Catherine M Tangen, Phyllis J Goodman, Ian M Thompson, Jyotsna Batra, Suzanne Chambers, Leire Moya, Judith Clements, Lisa Horvath, Wayne Tilley, Gail P Risbridger, Henrik Gronberg, Markus Aly, Tobias Nordström, Paul Pharoah, Nora Pashayan, Johanna Schleutker, Teuvo L J Tammela, Csilla Sipeky, Anssi Auvinen, Demetrius Albanes, Stephanie Weinstein, Alicja Wolk, Niclas Håkansson, Catharine M L West, Alison M Dunning, Neil Burnet, Lorelei A Mucci, Edward Giovannucci, Gerald L Andriole, Olivier Cussenot, Géraldine Cancel-Tassin, Stella Koutros, Laura E Beane Freeman, Karina Dalsgaard Sorensen, Torben Falck Orntoft, Michael Borre, Lovise Maehle, Eli Marie Grindedal, David E Neal, Jenny L Donovan, Freddie C Hamdy, Richard M Martin, Ruth C Travis, Tim J Key, Robert J Hamilton, Neil E Fleshner, Antonio Finelli, Sue Ann Ingles, Mariana C Stern, Barry S Rosenstein, Sarah L Kerns, Harry Ostrer, Yong-Jie Lu, Hong-Wei Zhang, Ninghan Feng, Xueying Mao, Xin Guo, Guomin Wang, Zan Sun, Graham G Giles, Melissa C Southey, Robert J MacInnis, Liesel M FitzGerald, Adam S Kibel, Bettina F Drake, Ana Vega, Antonio Gómez-Caamaño, Robert Szulkin, Martin Eklund, Manolis Kogevinas, Javier Llorca, Gemma Castaño-Vinyals, Kathryn L Penney, Meir Stampfer, Jong Y Park, Thomas A Sellers, Hui-Yi Lin, Janet L Stanford, Cezary Cybulski, Dominika Wokolorczyk, Jan Lubinski, Elaine A Ostrander, Milan S Geybels, Børge G Nordestgaard, Sune F Nielsen, Maren Weischer, Rasmus Bisbjerg, Martin Andreas Røder, Peter Iversen, Hermann Brenner, Katarina Cuk, Bernd Holleczek, Christiane Maier, Manuel Luedeke, Thomas Schnoeller, Jeri Kim, Christopher J Logothetis, Esther M John, Manuel R Teixeira, Paula Paulo, Marta Cardoso, Susan L Neuhausen, Linda Steele, Yuan Chun Ding, Kim De Ruyck, Gert De Meerleer, Piet Ost, Azad Razack, Jasmine Lim, Soo-Hwang Teo, Daniel W Lin, Lisa F Newcomb, Davor Lessel, Marija Gamulin, Tomislav Kulis, Radka Kaneva, Nawaid Usmani, Sandeep Singhal, Chavdar Slavov, Vanio Mitev, Matthew Parliament, Frank Claessens, Steven Joniau, Thomas Van den Broeck, Samantha Larkin, Paul A Townsend, Claire Aukim-Hastie, Manuela Gago-Dominguez, Jose Esteban Castelao, Maria Elena Martinez, Monique J Roobol, Guido Jenster, Ron H N van Schaik, Florence Menegaux, Thérèse Truong, Yves Akoli Koudou, Jianfeng Xu, Kay-Tee Khaw, Lisa Cannon-Albright, Hardev Pandha, Agnieszka Michael, Stephen N Thibodeau, Shannon K McDonnell, Daniel J Schaid, Sara Lindstrom, Constance Turman, Jing Ma, David J Hunter, Elio Riboli, Afshan Siddiq, Federico Canzian, Laurence N Kolonel, Loic Le Marchand, Robert N Hoover, Mitchell J Machiela, Zuxi Cui, Peter Kraft, Christopher I Amos, David V Conti, Douglas F Easton, Fredrik Wiklund, Stephen J Chanock, Brian E Henderson, Zsofia Kote-Jarai, Christopher A Haiman, Rosalind A Eeles,

Affiliations

  1. Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA.
  2. Seidman Cancer Center, University Hospitals, Cleveland, OH, USA.
  3. Royal Marsden NHS Foundation Trust, London, UK.
  4. Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK. [email protected].
  5. Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. [email protected].
  6. Royal Marsden NHS Foundation Trust, London, UK. [email protected].
  7. Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.
  8. Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
  9. Institute of Cancer Research, London, UK.
  10. Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
  11. Fundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica, CIBERER, IDIS, Santiago de Compostela, Spain.
  12. Department of Oncology, Centre for Cancer Genetic Epidemiology, Strangeways Laboratory, University of Cambridge, Cambridge, UK.
  13. Division of Population Health, Health Services Research and Primary Care, University of Manchester, Manchester, UK.
  14. Warwick Medical School, University of Warwick, Coventry, UK.
  15. Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA.
  16. SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  17. CHRISTUS Santa Rosa Hospital-Medical Center, San Antonio, TX, USA.
  18. Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.
  19. Australian Prostate Cancer Research Centre-Qld, Translational Research Institute, Brisbane, Queensland, Australia.
  20. Menzies Health Institute of Queensland, Griffith University, Nathan, Queensland, Australia.
  21. Cancer Council Queensland, Fortitude Valley, Queensland, Australia.
  22. Chris O'Brien Lifehouse (COBLH), Camperdown, New South Wales, Australia.
  23. Garvan Institute of Medical Research, Sydney, New South Wales, Australia.
  24. Dame Roma Mitchell Cancer Research Centre, University of Adelaide, Adelaide, South Australia, Australia.
  25. Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Program, Department of Anatomy and Developmental Biology, Monash University, Victoria, Australia.
  26. Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia.
  27. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  28. Department of Urology, Karolinska University Hospital, Stockholm, Sweden.
  29. Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  30. Department of Clinical Sciences at Danderyds Hospital, Karolinska Institutet, Stockholm, Sweden.
  31. Department of Applied Health Research, University College London, London, UK.
  32. Institute of Biomedicine, University of Turku, Turku, Finland.
  33. Tyks Microbiology and Genetics, Department of Medical Genetics, Turku University Hospital, Turku, Finland.
  34. Department of Urology, Tampere University Hospital and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
  35. Department of Epidemiology, School of Health Sciences, University of Tampere, Tampere, Finland.
  36. Division of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
  37. Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
  38. Division of Cancer Sciences, Manchester Cancer Research Centre, Manchester Academic Health Science Centre and Christie NHS Foundation Trust, University of Manchester, Manchester, UK.
  39. Department of Oncology, Oncology Centre, Cambridge University Hospitals NHS Foundation Trust, University of Cambridge, Cambridge, UK.
  40. Department of Epidemiology, Harvard T.H., Chan School of Public Health, Boston, MA, USA.
  41. Washington University School of Medicine, St. Louis, MO, USA.
  42. UPMC Sorbonne Universités, GRC no. 5 ONCOTYPE-URO, Tenon Hospital, Paris, France.
  43. CeRePP, Tenon Hospital, Paris, France.
  44. Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
  45. Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  46. Department of Urology, Aarhus University Hospital, Aarhus, Denmark.
  47. Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.
  48. Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.
  49. Cancer Research UK, Cambridge Research Institute, Cambridge, UK.
  50. Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK, Faculty of Medical Science, John Radcliffe Hospital, University of Oxford, Oxford, UK.
  51. School of Social and Community Medicine, University of Bristol, Bristol, UK.
  52. Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  53. Department of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  54. Division of Urology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  55. Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  56. Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  57. Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY, USA.
  58. Department of Pathology, Albert Einstein College of Medicine, Bronx, NY, USA.
  59. Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  60. Second Military Medical University, Shanghai, China.
  61. Wuxi Second Hospital, Nanjing Medical University, Wuxi, China.
  62. Department of Urology, First Affiliated Hospital, Chongqing Medical University, Chongqing, China.
  63. Department of Urology, Zhongshan Hospital, Fudan University Medical College, Shanghai, China.
  64. People's Hospital of Liaoning Province, People's Hospital of China Medical University, Shenyang, China.
  65. Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
  66. Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.
  67. Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
  68. Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.
  69. Division of Urologic Surgery, Brigham and Womens Hospital, Boston, MA, USA.
  70. Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
  71. Division of Family Medicine, Department of Neurobiology, Care Science and Society, Karolinska, Institutet, Huddinge, Sweden.
  72. Scandinavian Development Services, Danderyd, Sweden.
  73. ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
  74. CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  75. IMIM (Hospital del Mar Research Institute), Barcelona, Spain.
  76. Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  77. University of Cantabria-IDIVAL, Santander, Spain.
  78. Department of Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  79. Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA.
  80. Biostatistics Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
  81. Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  82. Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA.
  83. International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  84. National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
  85. Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  86. Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  87. Department of Urology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  88. Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  89. Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  90. German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  91. Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  92. Saarland Cancer Registry, Saarbrücken, Germany.
  93. Institute for Human Genetics, University Hospital Ulm, Ulm, Germany.
  94. Department of Urology, University Hospital Ulm, Ulm, Germany.
  95. Department of Genitourinary Medical Oncology, University of Texas-MD Anderson Cancer Center, Houston, TX, USA.
  96. Cancer Prevention Institute of California, Fremont, CA, USA.
  97. Department of Health Research & Policy (Epidemiology) and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
  98. Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal.
  99. Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal.
  100. Department of Population Sciences, Beckman Research Institute of the City of Hope, Duarte, CA, USA.
  101. Faculty of Medicine and Health Sciences, Basic Medical Sciences, Ghent University, Ghent, Belgium.
  102. Department of Radiotherapy, Ghent University Hospital, Ghent, Belgium.
  103. Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
  104. Cancer Research Malaysia (CRM), Outpatient Centre, Subang Jaya Medical Centre, Selangor, Malaysia.
  105. Department of Urology, University of Washington, Seattle, WA, USA.
  106. Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  107. Department of Oncology, Division of Medical Oncology, Urogenital Unit, University Hospital Centre Zagreb, Zagreb, Croatia.
  108. Department of Urology, University Hospital Center Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia.
  109. Molecular Medicine Center, Department of Medical Chemistry and Biochemistry, Medical University of Sofia, Sofia, Bulgaria.
  110. Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada.
  111. Division of Radiation Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada.
  112. Department of Urology and Alexandrovska University Hospital, Medical University of Sofia, Sofia, Bulgaria.
  113. Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
  114. Department of Urology, University Hospitals Leuven, Leuven, Belgium.
  115. University of Southampton, Southampton General Hospital, Southampton, UK.
  116. Division of Cancer Sciences, Manchester Cancer Research Centre, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Center, NIHR Manchester Biomedical Research Centre, Health Innovation Manchester, University of Manchester, Manchester, UK.
  117. University of Surrey, Guildford, Surrey, UK.
  118. Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, Servicio Galego de Saúde, SERGAS, Santiago de Compostela, Spain.
  119. Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
  120. Genetic Oncology Unit, CHUVI Hospital, Instituto de Investigación Biomédica Galicia Sur (IISGS), Complexo Hospitalario Universitario de Vigo, Vigo, Spain.
  121. Department of Family Medicine and Public Health, Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
  122. Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  123. Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands.
  124. Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France.
  125. Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA.
  126. Clinical Gerontology Unit, University of Cambridge, Cambridge, UK.
  127. Division of Genetic Epidemiology, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.
  128. George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT, USA.
  129. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  130. Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
  131. Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  132. Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  133. Genomics England, Queen Mary University of London, London, UK.
  134. Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  135. Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
  136. Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
  137. Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
  138. Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
  139. Institute of Cancer Research, London, UK. [email protected].
  140. Royal Marsden NHS Foundation Trust, London, UK. [email protected].

PMID: 30622367 DOI: 10.1038/s41588-018-0330-6

Abstract

In the version of this article initially published, the name of author Manuela Gago-Dominguez was misspelled as Manuela Gago Dominguez. The error has been corrected in the HTML and PDF version of the article.

Publication Types

Grant support